Status:
COMPLETED
Preparation for End-of-Life Decision Making in Mild Dementia
Lead Sponsor:
Emory University
Collaborating Sponsors:
National Institute on Aging (NIA)
Conditions:
Dementia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The proposed study will adapt and pilot test an efficacious advance care planning interventions, Sharing Patient's Illness Representations to Increase Trust (SPIRIT), with patients with mild dementia ...
Detailed Description
Progressive memory loss and impairment of reasoning and judgment are the main symptoms of dementia (including Alzheimer's Disease). For this reason, people in the early stages of dementia are encourag...
Eligibility Criteria
Inclusion
- Inclusion Criteria for Patients with Mild to Moderate Dementia:
- A diagnosis of mild to moderate dementia based on a Montreal Cognitive Assessment (MoCA) score greater than or equal to 13, or Mini-Mental State Examination (MMSE) score greater than or equal to 18
- Have access to a computer and internet connectivity in a private setting (either the patient or the surrogate has access to a computer and internet connectivity)
- Have decision-making capacity to consent to a low-risk study determined by a score greater than or equal to 11 on the University of California San Diego Brief Assessment of Capacity to Consent (UBACC)
- Able to understand and speak English
- Exclusion Criteria for Patients with Mild to Moderate dementia:
- Lack of an available surrogate
- Uncompensated hearing deficits
- Speech impairment
- Inclusion Criteria for Surrogates:
- 18 years or older (to serve as a surrogate decision-maker, the individual must be an adult)
- Be chosen by the patient to serve as a surrogate decision-maker
- Have access to a computer and internet connectivity in a private setting (either the patient or the surrogate has access to a computer and internet connectivity)
- Able to understand and speak English
- Exclusion Criteria for Surrogates:
- Inability to complete questionnaires due to physical or cognitive limitations
Exclusion
Key Trial Info
Start Date :
May 4 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 7 2022
Estimated Enrollment :
242 Patients enrolled
Trial Details
Trial ID
NCT03311711
Start Date
May 4 2018
End Date
December 7 2022
Last Update
April 11 2023
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Assisted Living Facilities in the Metro Atlanta Area
Atlanta, Georgia, United States, 30030
2
Grady Health System
Atlanta, Georgia, United States, 30303
3
Emory Clinic Geriatrics
Atlanta, Georgia, United States, 30329
4
Rush Alzheimer's Disease Center
Chicago, Illinois, United States, 60612